A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Delray Medical Center WATCHMAN FLX Device for Atrial Fibrillation Now Offered to Patients

Delray Medical Center now offers the WATCHMAN FLX™ for patients who have a high risk of stroke with non-valvular atrial fibrillation (NVAF) who need an alternative to oral anticoagulation therapy by permanently closing off the left atrial appendage-the area of the heart where stroke-causing blood clots commonly form in NAVF.

Delray Medical Center Dr. Martin Kloosterman, electrophysiologist on staff said, “People with atrial fibrillation are at an increased risk of stroke if they are not on blood thinners, which can also increase the risk of bleeding. This can often result in higher mortality and disability rates because of an injury to the brain or other affected areas.” He added, “We are pleased to have available a new generation of the Watchman FLX device, which expands the number of patients who can benefit from this life-saving technology.”

This technology features a new, fully rounded design offering physicians the ability to safely enter, and maneuver within the left atrial appendage.  It is the first LAAC device that can be fully recaptured, repositioned and redeployed for precise placement, and the new frame design allows for optimal device engagement with the tissue for long-term stability and a faster, more complete seal.

“This advanced technology gives us a new option to treat patients who are at high risk for stroke, that could also enable them to have a better long-term quality of life,” said Maggie Gill, chief executive officer for the Palm Beach Health Network and Delray Medical Center. “We remain committed to providing patients in Palm Beach County with comprehensive cardiovascular treatment options close to home, and in a safe environment.”

Atrial Fibrillation is a common heart disorder which occurs when electrical signals in the heart become irregular, causing the heart’s upper chamber to beat out of rhythm.  Atrial fibrillation requires immediate medical attention because it could lead to a life-threatening stroke, which is otherwise preventable.

When it comes to you, your family, and your health, Delray Medical Center and its cardiovascular team knows what it take to give you the care you need quickly and compassionately.  During a health emergency, you need health care you can trust.  At Delray Medical Center, we believe that is exactly what you will find.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy